Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Cohort of HIV-infected Children With Resistance or Intolerance to Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI) First Line and PI Second Line Antiretroviral Therapy

NCT01225406 is registered in ClinicalTrials.gov with The HIV Netherlands Australia Thailand Research Collaboration as lead sponsor.

NCT NCT01225406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Cohort of HIV-infected Children With Resistance or Intolerance to Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI) First Line and PI Second Line Antiretroviral Therapy
Lead sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
December 31, 2013
Enrollment
56 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

this study is designed to collect treatment data of thai children on third line arv therapy